Want to see KR:185750 full AI Analyst Report?
Chong Kun Dang Pharmaceutical Corp. (185750) Financial Statements
Chong Kun Dang Pharmaceutical Corp. Financial Overview
Chong Kun Dang Pharmaceutical Corp.'s market cap is currently $831.41B. The company's EPS TTM is $6031.21; its P/E ratio is 10.46; and it has a dividend yield of 0.79%. Chong Kun Dang Pharmaceutical Corp. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.69T | $ 1.59T | $ 1.67T | $ 1.49T | $ 1.34T |
| Gross Profit | $ 517.23B | $ 532.61B | $ 662.20B | $ 542.64B | $ 495.82B |
| Operating Income | $ 80.57B | $ 99.46B | $ 246.60B | $ 109.91B | $ 94.76B |
| EBITDA | $ 125.37B | $ 150.10B | $ 287.62B | $ 137.61B | $ 112.71B |
| Net Income | $ 77.83B | $ 109.07B | $ 212.52B | $ 80.95B | $ 42.72B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 346.50B | $ 302.17B | $ 365.07B | $ 155.86B | $ 187.33B |
| Total Assets | $ 1.80T | $ 1.46T | $ 1.40T | $ 1.12T | $ 1.05T |
| Total Debt | $ 367.76B | $ 188.15B | $ 219.76B | $ 235.74B | $ 237.05B |
| Net Debt | $ 151.52B | $ -40.32B | $ 117.53M | $ 118.32B | $ 105.24B |
| Total Liabilities | $ 793.94B | $ 562.39B | $ 586.79B | $ 503.59B | $ 480.89B |
| Stockholders' Equity | $ 1.00T | $ 893.97B | $ 815.69B | $ 622.39B | $ 566.01B |
| Cash Flow | |||||
| Free Cash Flow | $ -73.49B | $ -1.81B | $ 249.35B | $ 14.67B | $ -38.94B |
| Operating Cash Flow | $ 67.36B | $ 64.29B | $ 318.16B | $ 67.73B | $ 12.90B |
| Investing Cash Flow | $ -245.28B | $ 3.73B | $ -171.31B | $ -65.38B | $ -90.81B |
| Financing Cash Flow | $ 166.96B | $ -63.11B | $ -43.70B | $ -16.34B | $ 85.14B |
Currency in KRW